Cancer cases are globally on the rise, causing an increasing demand for their treatment. Highly active pharmaceutical ingredients (APIs) are the key compounds for chemotherapies, combination therapies in particular. Business Line Pharmaceutical Ingredients at Heraeus Precious Metals specializes in the production of generic APIs.
In 2021, Heraeus made a significant multi-million Euro investment building up its manufacturing capacity for platinum-based pharmaceutical ingredients to fight cancer. This is the company’s response to the global increase in demand for cancer drugs while consolidating its position as one of the leading manufacturers for platinum-based active ingredients.
The high purity of our highly active pharmaceutical ingredients supports efficient customers processes and consistently high quality for their products. Continuous enhancement of our knowledge contributes to customers’ ability to maintain compliance with changing regulations and to long-term drug supply. Discover our API portfolio by selecting a product below.
Quality Management
Extensive analytical capabilities, quality assurance and the reliability of a global partner are extremely important for the pharmaceutical industry. Heraeus constantly secures the quality of its APIs, follows strictly international regulations and prepares and maintains all documentation for initial and existing registrations worldwide.
A successful registration, based on transparent communication with clients and authorities, not only permits entry to markets all over the world, but also confirms that Heraeus demonstrates compliance with stringent regulatory requirements for its APIs.

To consistently maintain high quality standards for its APIs, Heraeus regularly reviews and improves internal standards and processes related to quality and safety.

Heraeus is equipped with the state-of-the-art analytical techniques: process controls, analysis of raw materials, intermediates, and release testing of APIs are conducted in compliance with cGMP and ICH guidelines.


Highly Active Pharmaceutical Ingredients (APIs)
